Sleep Treatments | Sleep Review
ProSomnus Sleep Technologies has appointed John E. Remmers, MD, to its leadership team. Remmers will provide expert medical and strategic advice on a range of initiatives including research and development, regulatory approvals, corporate strategy, medical training and clinical investigations.
“Millions of people around the world are breathing, thanks to the myriad contributions of Dr. John Remmers sleeps better, ”said Len Liptak, CEO of ProSomnus, in a press release. “John is a pioneer in the research, medical education, clinical practice, and technology that are essential to the diagnosis and treatment of OSA. ProSomnus is honored to work with John to further develop ProSomnus device therapy devices as the leading treatment option. “
John E. Remmers, MD
John E. Remmers, MD, said in a press release, “Joining ProSomnus is one of the greatest opportunities of my career. ProSomnus is already a leader in digital manufacturing of oral devices for sleep apnea. The company is now pursuing new approaches that bring my expertise and background in this field to the table. I look forward to partnering with ProSomnus to improve sleep apnea treatment. “
Remmers has developed products that range from portable diagnostic sleep monitors to automatically titrating CPAP devices, including proactive algorithms to automatically adjust the CPAP pressure to the needs of the patient. He served two terms as Editor-in-Chief of the Journal of Applied Physiology and has given honorary research lectures to the American Thoracic Society, the American Physiological Society, and the American College of Chest Physicians. His research interests lie in the neurobiology of respiratory rhythmogenesis, chemoreception, and the pathophysiology of breath control. Remmers has published over a hundred peer-reviewed publications in the field of respiratory physiology. He founded the Foothills Medical Center and Sleep Lab in Calgary and was a clinical professor of internal medicine at the University of Calgary, where he is still active on several programs today.